Page last updated: 2024-09-04

gadolinium dtpa and Central Nervous System Diseases

gadolinium dtpa has been researched along with Central Nervous System Diseases in 37 studies

Research

Studies (37)

TimeframeStudies, this research(%)All Research%
pre-19904 (10.81)18.7374
1990's26 (70.27)18.2507
2000's7 (18.92)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacobs, PM; Manninger, SP; Muldoon, LL; Murillo, T; Nesbit, G; Neuwelt, EA1
Ito, K; Kobayashi, S; Kurihara, K; Nakamura, I; Tanno, M1
Belahsen, MF; Maaroufi, M; Messouak, O; Sqalli, N; Tizniti, S1
Anzalone, N; Bowen, BC; Essig, M; Gustafsson, L; Knopp, MV; Kremer, S; Kuhn, MJ; Maldjian, JA; Maravilla, KR; Runge, VM; Schmalfuss, IM; Wippold, FJ; Wolansky, LJ1
Esparza, J; Hinojosa, J; Muñoz, A1
Boyer, L; Bruneton, JN; Chanalet, S; Laffont, J; Masson, B1
Aslanian, V; Borseth, A; Bunouf, P; Lambrechts, M; Lemaignen, H; Lundby, B; Schiratti, M; Svaland, M1
Akeson, P; Haugen, I; Holtås, S; Jonsson, E1
Nelson, KL; Runge, VM1
Kuijpers, TJ; Oudkerk, M; Sijens, PE; Van Beek, EJ1
Enzmann, DR; Haros, SP; Mehta, RC; Pike, GB1
Andrew, E; Hugo, F; LaFrance, N; Lundby, B; Svaland, M1
Baert, AL; Børseth, A; De Greef, D; Demaerel, P; Marchal, G; Van Calenbergh, F; Wilms, G1
Christensen, T; Lundorf, E; Svaland, MG1
Berry, I; Brugières, P; de Schepper, AM; Degryse, HR; Gaston, A; Le Bras, F; Manelfe, C; Marsault, C; Parizel, PM; Wichmann, W1
Beck, W; Haustein, J; Kaiser, W; Laniado, M; Louton, T; Niendorf, HP; Planitzer, J; Reiser, M; Schöffel, M; Schörner, W1
Aisen, AM; Bradley, WG; Brant-Zawadzki, M; Dreisbach, JN; Haughton, VM; Kumar, AJ; Maravilla, KR; McNamara, MT; Sze, G; Weinreb, JC2
Ekholm, S; Fagerlund, M; Holtås, S; Isberg, B; Jonsson, E; Lindell, D; Lindén, B; Sandvik, L; Sjöberg, S; Thuomas , KA; Tollesson, PO1
Aslanian, V; Borseth, A; Bunouf, P; Lemaignen, H; Lundby, B; Svaland, MG1
Gordon, P; Hugo, F; Lundby, B1
Ashimine, K; Eto, Y; Maekawa, K; Sugama, S; Yoshimura, H1
Fukusako, T; Kato, M; Mochizuki, T; Morimatsu, M; Negaro, K; Nogaki, H1
Doringer, W; Hergan, K; Oser, W1
Caldemeyer, KS; Greenspan, SL; Lowe, MJ; Mathews, VP; Ulmer, JL; Weber, DM1
Brunberg, JA; Grodd, W; Grossman, RI; Haughton, VM; Heindel, W; Hunter, G; Jinkins, JR; Kanal, E; Kristy, RM; Kuhn, MJ; Lee, D; Leeds, N; Maravilla, K; Provenzale, JM; Ramsey, R; Rubin, DL; Simon, J; Stevens, GR; Sze, G; Truwit, C; Tu, R; Wippold, FJ; Zelch, J1
Jinkins, JR; Muroff, LR; Runge, VM1
Bydder, GM1
Brant-Zawadzki, M1
Greco, A; Lanthiez, P; McNamara, MT; Michelozzi, G; Quay, SC1
Gelblum, DY; Runge, VM1
Baierl, P; Bauer, WM; Fendel, H; Förster, C; Haustein, J; Mühlsteffen, A; Niendorf, HP1
Girard, N; Grégoire, N; Lavanga, A; Momose, T; Perot, S; Rumeau, C; Salamon, G1
Carollo, BR; Gelblum, DY; Nelson, KL; Runge, VM; Wolf, CR1
Freeman, MW; Kessler, RM; Partain, CL; Powers, TA; Robertson, RH; Whelan, HT; Wyatt, SH1
Iio, M; Kono, T; Mano, I; Terao, H; Tsuchida, T; Yoshida, H1
Iio, M1

Reviews

6 review(s) available for gadolinium dtpa and Central Nervous System Diseases

ArticleYear
Basic principles of MR contrast.
    Topics in magnetic resonance imaging : TMRI, 1995,Summer, Volume: 7, Issue:3

    Topics: Central Nervous System Diseases; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Organometallic Compounds; Oxides; Pentetic Acid

1995
Central nervous system: review of clinical use of contrast media.
    Topics in magnetic resonance imaging : TMRI, 2001, Volume: 12, Issue:4

    Topics: Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Organometallic Compounds

2001
Technical advances in magnetic resonance imaging.
    Current opinion in neurology and neurosurgery, 1992, Volume: 5, Issue:6

    Topics: Central Nervous System; Central Nervous System Diseases; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid

1992
Pitfalls of contrast-enhanced imaging in the nervous system.
    Magnetic resonance in medicine, 1991, Volume: 22, Issue:2

    Topics: Central Nervous System Diseases; Central Nervous System Neoplasms; Contrast Media; Costs and Cost Analysis; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid

1991
The role of gadolinium-diethylenetriaminepentaacetic acid in the evaluation of the central nervous system.
    Magnetic resonance quarterly, 1990, Volume: 6, Issue:2

    Topics: Central Nervous System; Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Organometallic Compounds; Pentetic Acid

1990
Gd DTPA: a review of clinical indications in central nervous system magnetic resonance imaging.
    Radiographics : a review publication of the Radiological Society of North America, Inc, 1989, Volume: 9, Issue:5

    Topics: Brain Neoplasms; Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Prospective Studies; Spinal Diseases

1989

Trials

19 trial(s) available for gadolinium dtpa and Central Nervous System Diseases

ArticleYear
Contrast enhancement of central nervous system lesions: multicenter intraindividual crossover comparative study of two MR contrast agents.
    Radiology, 2006, Volume: 240, Issue:2

    Topics: Central Nervous System Diseases; Contrast Media; Cross-Over Studies; Double-Blind Method; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Statistics, Nonparametric

2006
Cisternography and ventriculography gadopentate dimeglumine-enhanced MR imaging in pediatric patients: preliminary report.
    AJNR. American journal of neuroradiology, 2007, Volume: 28, Issue:5

    Topics: Adolescent; Arachnoiditis; Brain Neoplasms; Central Nervous System Diseases; Cerebral Ventriculography; Child; Child, Preschool; Contrast Media; Female; Gadolinium DTPA; Humans; Hydrocephalus; Infant; Infant, Newborn; Injections, Spinal; Magnetic Resonance Imaging; Male; Meningomyelocele; Myelography; Pilot Projects; Skull Fractures; Subarachnoid Space

2007
[Comparative studies of the tolerability of gadodiamide, dimeglumine gadopentetate and meglumine gadoterate in MRI tests of the central nervous system].
    Journal de radiologie, 1995, Volume: 76, Issue:7

    Topics: Adult; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Drug Combinations; Drug Hypersensitivity; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Risk Factors

1995
[Clinical evaluation of the tolerability of gadodiamide, a new nonionic contrast agent in MRI of the central nervous system].
    Journal de radiologie, 1995, Volume: 76, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Contrast Media; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid

1995
Contrast-enhanced MRI of the central nervous system: comparison between gadodiamide injection and gadolinium-DTPA.
    Neuroradiology, 1995, Volume: 37, Issue:3

    Topics: Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid

1995
Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system.
    Investigative radiology, 1995, Volume: 30, Issue:2

    Topics: Adult; Aged; Central Nervous System; Central Nervous System Diseases; Chi-Square Distribution; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid

1995
Clinical experience with gadodiamide injection in magnetic resonance imaging of the central nervous system.
    Investigative radiology, 1994, Volume: 29 Suppl 2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid

1994
Gadodiamide injection at 0.1 and 0.3 mmol/kg body weight: a phase III double-blind, parallel, randomised clinical investigation of known or suspected central nervous system lesions at 1.5 T.
    Neuroradiology, 1994, Volume: 36, Issue:5

    Topics: Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid

1994
Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
    Acta radiologica (Stockholm, Sweden : 1987), 1994, Volume: 35, Issue:4

    Topics: Adult; Aged; Bilirubin; Blood Pressure; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Safety; Spinal Cord Diseases

1994
Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA).
    Neuroradiology, 1994, Volume: 36, Issue:1

    Topics: Adult; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid

1994
Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.
    Radiology, 1993, Volume: 186, Issue:3

    Topics: Adult; Central Nervous System Diseases; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid

1993
Use of the magnetic resonance contrast agent gadodiamide in the central nervous system. Results of a multicenter trial.
    Investigative radiology, 1993, Volume: 28 Suppl 1

    Topics: Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid

1993
Tolerance and efficacy of Omniscan (gadodiamide injection) in MR imaging of the central nervous system.
    Acta radiologica (Stockholm, Sweden : 1987), 1996, Volume: 37, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Central Nervous System Diseases; Contrast Media; Drug Tolerance; Female; Gadolinium; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Surveys and Questionnaires

1996
Evaluation of the clinical safety of gadodiamide injection, a new nonionic MRI contrast medium for the central nervous system: a European perspective.
    Neuroradiology, 1996, Volume: 38, Issue:6

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Central Nervous System Diseases; Contrast Media; Europe; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid

1996
MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications.
    European journal of radiology, 1996, Volume: 23, Issue:3

    Topics: Adolescent; Central Nervous System Diseases; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Infant; Infant, Newborn; Magnetic Resonance Imaging; Meglumine; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid; Randomized Controlled Trials as Topic; Safety

1996
Magnetic resonance imaging in patients with central nervous system pathology: a comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA).
    Investigative radiology, 2000, Volume: 35, Issue:7

    Topics: Adult; Aged; Brain; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Male; Middle Aged; Organometallic Compounds; Spinal Cord

2000
Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine.
    Radiology, 1991, Volume: 181, Issue:3

    Topics: Brain; Central Nervous System Diseases; Contrast Media; Drug Evaluation; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Spinal Cord

1991
Gadodiamide injection: nonionic gadolinium chelate for MR imaging of the brain and spine--phase II-III clinical trial.
    Radiology, 1990, Volume: 176, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Central Nervous System Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Spinal Cord Neoplasms; Spine

1990
Central nervous system lesions in pediatric patients: Gd-DTPA-enhanced MR imaging.
    Radiology, 1988, Volume: 169, Issue:3

    Topics: Adolescent; Astrocytoma; Brain Neoplasms; Central Nervous System Diseases; Child; Child, Preschool; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Multicenter Studies as Topic; Organometallic Compounds; Pentetic Acid

1988

Other Studies

12 other study(ies) available for gadolinium dtpa and Central Nervous System Diseases

ArticleYear
An exploratory study of ferumoxtran-10 nanoparticles as a blood-brain barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions.
    AJNR. American journal of neuroradiology, 2005, Volume: 26, Issue:9

    Topics: Adolescent; Adult; Aged; Blood-Brain Barrier; Brain; Brain Neoplasms; Central Nervous System Diseases; Cerebrovascular Disorders; Contrast Media; Demyelinating Diseases; Dextrans; Female; Ferrosoferric Oxide; Gadolinium DTPA; Humans; Inflammation; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Middle Aged; Nanostructures; Oxides; Phagocytes

2005
New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients.
    Clinical rheumatology, 2006, Volume: 25, Issue:6

    Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Central Nervous System Diseases; Contrast Media; Demyelinating Diseases; Female; Gadolinium DTPA; Humans; Infliximab; Magnetic Resonance Imaging; Male; Middle Aged; Steroids; Tumor Necrosis Factor-alpha

2006
[Spinal tuberculous arachnoiditis with intradural extramedullary tuberculomas].
    Journal of neuroradiology = Journal de neuroradiologie, 2006, Volume: 33, Issue:2

    Topics: Adult; Arachnoiditis; Central Nervous System Diseases; Contrast Media; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Tuberculoma; Tuberculosis, Meningeal; Tuberculosis, Spinal

2006
Central nervous system tumor, infection, and infarction: detection with gadolinium-enhanced magnetization transfer MR imaging.
    Radiology, 1995, Volume: 195, Issue:1

    Topics: Adult; Aged; Brain; Brain Neoplasms; Central Nervous System Diseases; Cerebral Infarction; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies

1995
Enhanced magnetic resonance imaging of leptomeningeal angiomatosis.
    Pediatric neurology, 1997, Volume: 17, Issue:3

    Topics: Angiomatosis; Central Nervous System Diseases; Child; Child, Preschool; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meninges; Tomography, X-Ray Computed

1997
[Magnetic resonance imaging of a case of central nervous system tuberculosis with tuberculous arachnoiditis and multiple tuberculomas].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1997, Volume: 34, Issue:10

    Topics: Arachnoiditis; Central Nervous System Diseases; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Tuberculoma; Tuberculosis; Tuberculosis, Meningeal

1997
[Contrast-enhanced subtraction MRT in the spin-echo technic].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1998, Volume: 169, Issue:1

    Topics: Adolescent; Adult; Aged; Central Nervous System Diseases; Child; Child, Preschool; Contrast Media; Evaluation Studies as Topic; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Musculoskeletal Diseases; Retrospective Studies; Subtraction Technique

1998
Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging.
    Radiology, 1999, Volume: 211, Issue:1

    Topics: Brain; Brain Diseases; Central Nervous System Diseases; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phantoms, Imaging

1999
Comparison of plain and Gd-DTPA-enhanced MR-imaging in children.
    Pediatric radiology, 1990, Volume: 20, Issue:7

    Topics: Adolescent; Brain Neoplasms; Central Nervous System Diseases; Child; Child, Preschool; Female; Gadolinium; Gadolinium DTPA; Humans; Infant; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Spinal Cord Neoplasms

1990
[Gadolinium-DTPA in the study of intracranial tumors in the adult].
    Revue neurologique, 1990, Volume: 146, Issue:2

    Topics: Adult; Aged; Brain Neoplasms; Central Nervous System Diseases; Female; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organometallic Compounds; Pentetic Acid

1990
[The enhancement effects of Gd-DTPA for cerebrospinal lesions-- comparison with conventional T2-weighted images].
    Rinsho hoshasen. Clinical radiography, 1987, Volume: 32, Issue:13

    Topics: Central Nervous System Diseases; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid

1987
[Contrast-enhanced MRI and contrast medium development].
    Nihon rinsho. Japanese journal of clinical medicine, 1987, Volume: 45, Issue:1

    Topics: Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Spectroscopy; Organometallic Compounds; Pentetic Acid

1987